Home -> Law Blog Directory -> Personal Injury Law Blogs -> InjuryBoard
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: InjuryBoardSafety Fears Slow Prescription Drug Growth
By Jane Akre
.jpg)
LEARN MORE
IMAGE SOURCE:© iStockphoto/ pouring pills/ author: VisualField
|
Prescription drugs still fall in the plus column as a category for consumer spending, but last year retail spending on prescription slowed to the lowest rate in more than 40 years.
The Centers for Medicare and Medicaid Services reports that consumers are increasingly turning to generics to fill their drug needs largely because of a "growing concerns for drug safety."
Last year the Food and Drug Administration (FDA) was given new authority to issue the most serious warnings that a drug can lead to death - a "black box" warning.
There were 68 "black box" warnings issued by the FDAin 2007, compared to 58 warnings in 2006, and 21 issued in 2003, according to the report.
The agency was given the authority to mandate drug warnings by the Amendments Act of 2007. Previously the FDA could only request the manufacturer comply.
In the first demonstration of its new authority in 2007, the FDA ordered makers of older antipsychotics, such as thorazine and prolixin, to carry a new black box warning alerting physicians of their dangers.
Safety concerns may have added to the drug consumption slowdown - 4.9 percent or $228 billion. Drug spending peaked in 1999 at 18.8 percent, and slowed slightly in 2006 to 8.6 percent.
Older drugs that have generic versions are falling into favor because a) they've been around longer so have a more reliable safety record and b) they're cheaper because patents have expired on the more expensive blockbuster brand-name drugs.
Meanwhile, spending for other sectors of healthcare such as payments to hospitals, grew slightly last year, while the compensation for physician services declined due to a reduction in payments for Medicare patients authorized by Congress.
Whether consumers will continue to opt for generics or fewer drugs in general is a future uncertainty that will impact our national spending on health.
Despite slowed growth, health care costs continue to risse at an unsustainable rate of $2.2 trillion in 2007 or 16.2 percent of the gross domestic product, which is a record. #
Originally posted at InjuryBoard by Jane AkreFull post as published by InjuryBoard on January 08, 2009 (boomark / email).
Firestone Tire Problems Raise Questions of Safety
Are Your Car Tires Safe?
Baseball Players Named in Mitchell Report
Major League Baseball Players using Performance Enhancing Drugs
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Online Medication Sites
Prescription Drugs Sold Without Prescriptions
Safety Violations
Murphy Oil USA Inc. to pay $179,100 settlement in occupational safety violations lawsuit.
Westinghouse
alleging that former Westinghouse employees are being deprived of a choice in health care prescription plan benefits that were formerly available to them through union bargaining.
Bush Administration
class action settlement ensures Medicaid beneficiaries can continue to purchase prescription drugs at minimum cost when they become eligible for Medicare.
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters

AG Brown Goes After Prescription Drug Addicts
CA1: reselling prescription drugs causes loss
The DEA's Prescription Drug Problem:
Boston-Area In-House Counsel See Slow Growth in Legal Spending Ahead
Federal Agencies Join Forces Against Consumers







